L E López-Cortés1, C Velasco2, P Retamar3, M D del Toro3, J Gálvez-Acebal3, M de Cueto3, I García-Luque2, F J Caballero2, A Pascual4, J Rodríguez-Baño5. 1. Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain Spanish Network for Research in Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain luiselopezcortes@gmail.com. 2. Departamento de Microbiología, Universidad de Sevilla, Sevilla, Spain. 3. Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain Spanish Network for Research in Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain. 4. Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain Spanish Network for Research in Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain Departamento de Microbiología, Universidad de Sevilla, Sevilla, Spain. 5. Unidad Clínica de Enfermedades Infecciosas, Microbiología y Medicina Preventiva, Hospitales Universitarios Virgen Macarena y Virgen del Rocío, Sevilla, Spain Spanish Network for Research in Infectious Diseases, Instituto de Salud Carlos III, Madrid, Spain Departamento de Medicina, Universidad de Sevilla, Sevilla, Spain.
Abstract
OBJECTIVES: The known data about the influence of vancomycin MIC on Staphylococcus aureus bacteraemia are contradictory. Our objective was to study the possible impact of vancomycin MIC ≥1.5 mg/L on short- and medium-term mortality. METHODS: A prospective cohort study was carried out from March 2008 to January 2011 on adult patients with MSSA bacteraemia admitted to a tertiary hospital located in Seville (Spain). We studied the relationship between vancomycin MIC, accessory gene regulator (agr) type and absence of δ-haemolysin and poor prognosis. All isolates were genotyped by PFGE. Multivariate analysis, including a propensity score for having a vancomycin MIC of ≥1.5 mg/L, was performed by Cox regression. RESULTS: One hundred and thirty-five episodes of bacteraemia due to MSSA were included in the analysis. Twenty-nine (21.5%) isolates had a vancomycin MIC of ≥1.5 mg/L by Etest. There were no differences in agr distribution or absence of δ-haemolysin between isolates with reduced vancomycin susceptibility (RVS) and those without. RVS was not more frequent in specific clones; RVS was not associated with higher 14 or 30 day crude mortality (relative risk = 0.44, 95% CI = 0.14-1.35; and relative risk = 1.01, 95% CI = 0.52-1.96) rates, and it did not show higher rates of complicated bacteraemia (14.2% versus 13.8%, P = 0.61). Cox regression analysis did not significantly modify the results for 14 day mortality (HR = 0.39, 95% CI = 0.11-1.34) or 30 day mortality (HR = 0.89, 95% CI = 0.39-2.04). CONCLUSIONS: Contrary to previously published data, we did not find a relationship between RVS and higher mortality in patients with MSSA bacteraemia and we did not find a link with higher complicated bacteraemia rates.
OBJECTIVES: The known data about the influence of vancomycin MIC on Staphylococcus aureus bacteraemia are contradictory. Our objective was to study the possible impact of vancomycin MIC ≥1.5 mg/L on short- and medium-term mortality. METHODS: A prospective cohort study was carried out from March 2008 to January 2011 on adult patients with MSSA bacteraemia admitted to a tertiary hospital located in Seville (Spain). We studied the relationship between vancomycin MIC, accessory gene regulator (agr) type and absence of δ-haemolysin and poor prognosis. All isolates were genotyped by PFGE. Multivariate analysis, including a propensity score for having a vancomycin MIC of ≥1.5 mg/L, was performed by Cox regression. RESULTS: One hundred and thirty-five episodes of bacteraemia due to MSSA were included in the analysis. Twenty-nine (21.5%) isolates had a vancomycin MIC of ≥1.5 mg/L by Etest. There were no differences in agr distribution or absence of δ-haemolysin between isolates with reduced vancomycin susceptibility (RVS) and those without. RVS was not more frequent in specific clones; RVS was not associated with higher 14 or 30 day crude mortality (relative risk = 0.44, 95% CI = 0.14-1.35; and relative risk = 1.01, 95% CI = 0.52-1.96) rates, and it did not show higher rates of complicated bacteraemia (14.2% versus 13.8%, P = 0.61). Cox regression analysis did not significantly modify the results for 14 day mortality (HR = 0.39, 95% CI = 0.11-1.34) or 30 day mortality (HR = 0.89, 95% CI = 0.39-2.04). CONCLUSIONS: Contrary to previously published data, we did not find a relationship between RVS and higher mortality in patients with MSSA bacteraemia and we did not find a link with higher complicated bacteraemia rates.
Authors: J M Pericàs; J A Messina; C Garcia-de-la-Mària; L Park; B K Sharma-Kuinkel; F Marco; D Wray; Z A Kanafani; M Carugati; E Durante-Mangoni; P Tattevin; V H Chu; A Moreno; V G Fowler; J M Miró Journal: Clin Microbiol Infect Date: 2017-02-01 Impact factor: 8.067
Authors: Sean B Sullivan; Eloise D Austin; Stephania Stump; Barun Mathema; Susan Whittier; Franklin D Lowy; Anne-Catrin Uhlemann Journal: Antimicrob Agents Chemother Date: 2017-06-27 Impact factor: 5.191
Authors: Juan M Pericàs; Carlos Cervera; Cristina Garcia-de-la-Mària; Batu K Sharma-Kuinkel; Rachelle Gonzales; Asunción Moreno; Manel Almela; Carlos Falces; Eduard Quintana; David Fuster; Francesc Marco; Arnold S Bayer; Vance G Fowler; José M Miró Journal: Antimicrob Agents Chemother Date: 2020-02-21 Impact factor: 5.191
Authors: Rafael San-Juan; Esther Viedma; Fernando Chaves; Antonio Lalueza; Jesús Fortún; Elena Loza; Miquel Pujol; Carmen Ardanuy; Isabel Morales; Marina de Cueto; Elena Resino-Foz; Alejandra Morales-Cartagena; Alicia Rico; María P Romero; María Ángeles Orellana; Francisco López-Medrano; Mario Fernández-Ruiz; José María Aguado Journal: Emerg Infect Dis Date: 2016-06 Impact factor: 6.883
Authors: Soon Ok Lee; Shinwon Lee; Jeong Eun Lee; Kyoung-Ho Song; Chang Kyung Kang; Yu Mi Wi; Rafael San-Juan; Luis E López-Cortés; Alicia Lacoma; Cristina Prat; Hee-Chang Jang; Eu Suk Kim; Hong Bin Kim; Sun Hee Lee Journal: Sci Rep Date: 2020-11-26 Impact factor: 4.379